Galectin-1 protein therapy for the treatment for Laminin alpha2 related Congenital Muscular Dystrophy
Awardee: Pam Van Ry
Institution: University of Nevada School of Medicine
Award Amount: $35,000
Funding Period: January 1, 2015 - December 31, 2015
Previous
Previous
Epithelial-mesenchymal transition in paediatric airway epithelial cells following infection with bronchiolitis obliterans associated adenoviruses.
Next
Next